Does the TWEAK-Fn14 axis contribute to myocardial fibrosis?
Myocardial fibrosis is a condition where the heart muscle develops excessive collagen deposition, which can lead to impaired heart function. Research into the underlying causes of this condition focuses on identifying specific pathways and proteins that drive the progression of heart disease.
What the research says
The TWEAK-Fn14 axis, involving the cytokine TWEAK and its receptor Fn14, is linked to several heart conditions. Research indicates that this axis is involved in multiple heart issues, including inflammation, hypertrophy, and fibrosis 4. These processes contribute to the overall pathology of cardiac dysfunction.
Other factors also influence the development of myocardial fibrosis. For example, programmed cell death (PCD) pathways—such as apoptosis, ferroptosis, and necroptosis—play a significant role in activating cardiac fibroblasts and the synthesis of the extracellular matrix 3. Additionally, mitochondrial quality control is considered a central regulatory hub for maintaining heart health and preventing the progression of fibrosis 2.
What to ask your doctor
- How does the TWEAK-Fn14 axis specifically contribute to the progression of myocardial fibrosis?
- What role do programmed cell death pathways play in the development of heart tissue scarring?
- Are there specific biomarkers, such as T1 or T2 values on a cardiac MRI, that can help monitor the severity of myocardial fibrosis?
- How does mitochondrial health impact the progression of heart disease?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.